These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9598031)

  • 1. Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout.
    Takahashi S; Yamamoto T; Moriwaki Y; Tsutsumi Z; Yamakita J; Higashino K
    Adv Exp Med Biol; 1998; 431():57-60. PubMed ID: 9598031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout.
    Takahashi S; Yamamoto T; Moriwaki Y; Tsutsumi Z; Yamakita J; Higashino K
    Metabolism; 1998 Mar; 47(3):336-8. PubMed ID: 9500573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of xanthine oxidase and exercise on serum uric acid, 25(OH)D3, and calcium concentrations.
    Sanchis-Gomar F; Salvagno GL; Lippi G
    Clin Lab; 2014; 60(8):1409-11. PubMed ID: 25185430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In colorectal carcinoma patients, serum vitamin D levels vary according to stage of the carcinoma.
    Niv Y; Sperber AD; Figer A; Igael D; Shany S; Fraser G; Schwartz B
    Cancer; 1999 Aug; 86(3):391-7. PubMed ID: 10430245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Urate Lowering Therapy Using Allopurinol Improves Serum 25 Hydroxy Vitamin D in Stage 3-5 CKD Patients: A Pilot Study.
    Mohammed A; Marie MA; Abdulazim DO; Hassan M; Shaker O; Ayeldeen G; Salem MM; Sharaf El Din UA;
    Nephron; 2021; 145(2):133-136. PubMed ID: 33378761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with allopurinol decreases the number of acute gout attacks despite persistently elevated serum uric acid levels.
    Beutler AM; Rull M; Schlesinger N; Baker DG; Hoffman BI; Schumacher HR
    Clin Exp Rheumatol; 2001; 19(5):595. PubMed ID: 11579724
    [No Abstract]   [Full Text] [Related]  

  • 7. Potency on lowering serum uric acid in gout patients: a pooled analysis of registrative studies comparing febuxostat vs. allopurinol.
    Cutolo M; Cimmino MA; Perez-Ruiz F
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4186-4195. PubMed ID: 29028079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of uric acid on plasma levels of 1,25(OH)2D in renal failure.
    Vanholder R; Patel S; Hsu CH
    J Am Soc Nephrol; 1993 Oct; 4(4):1035-8. PubMed ID: 8286711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D Metabolites and Their Association with Calcium, Phosphorus, and PTH Concentrations, Severity of Illness, and Mortality in Hospitalized Equine Neonates.
    Kamr AM; Dembek KA; Reed SM; Slovis NM; Zaghawa AA; Rosol TJ; Toribio RE
    PLoS One; 2015; 10(6):e0127684. PubMed ID: 26046642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D status: effects on parathyroid hormone and 1, 25-dihydroxyvitamin D in postmenopausal women.
    Need AG; Horowitz M; Morris HA; Nordin BC
    Am J Clin Nutr; 2000 Jun; 71(6):1577-81. PubMed ID: 10837301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.
    Perez-Ruiz F; Alonso-Ruiz A; Calabozo M; Herrero-Beites A; García-Erauskin G; Ruiz-Lucea E
    Ann Rheum Dis; 1998 Sep; 57(9):545-9. PubMed ID: 9849314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label, 6-month study of allopurinol safety in gout: The LASSO study.
    Becker MA; Fitz-Patrick D; Choi HK; Dalbeth N; Storgard C; Cravets M; Baumgartner S
    Semin Arthritis Rheum; 2015 Oct; 45(2):174-83. PubMed ID: 26190562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular evaluation of vitamin D responsiveness of healthy young adults.
    Seuter S; Virtanen JK; Nurmi T; Pihlajamäki J; Mursu J; Voutilainen S; Tuomainen TP; Neme A; Carlberg C
    J Steroid Biochem Mol Biol; 2017 Nov; 174():314-321. PubMed ID: 27282116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study.
    Schumacher HR; Evans RR; Saag KG; Clower J; Jennings W; Weinstein SP; Yancopoulos GD; Wang J; Terkeltaub R
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1462-70. PubMed ID: 22549879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors.
    Shakhssalim N; Gilani KR; Parvin M; Torbati PM; Kashi AH; Azadvari M; Golestan B; Basiri A
    Urol Res; 2011 Feb; 39(1):1-7. PubMed ID: 20490785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Familial gout and nephropathy in a young woman. Report of one case].
    Badilla A; Rojas C
    Rev Med Chil; 2001 Jun; 129(6):666-70. PubMed ID: 11510209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.